Stephen J. Schueler, M.D.

Weight Management Orlistat

Orlistat (Xenical, Alli) works by slowing down the production of an enzyme (lipase) that breaks down fat in the stomach. This reduces the amount of dietary fat that can be digested by about 30 percent. Orlistat only works within the intestines, and not all over the body like the other diet drugs. Side effects of Orlistat are more common in those who do not follow a low-fat diet.

Diarrhea and cramps are common side effects in those who eat high fat foods when taking Orlistat. Other reported effects include oily spotting, flatulence with discharge, fecal urgency, fatty or oily stool, oily evacuation, increased defecation, and fecal incontinence. It may also interfere with absorption of vitamins A, D, and E.

Most experts recommend additional vitamin supplements for those taking this drug. Orlistat appears to be safe and effective for long-term weight loss.

At the end of the first year, many orlistat users can see an average 10% drop in body weight. Weight loss induced by orlistat can significantly reduce elevated blood pressure in overweight people. Weight loss with orlistat can also produce a significantly greater reduction in cholesterol levels.

Continue to Weight Management Phendimetrazine

Last Updated: Oct 3, 2008 References
Authors: Stephen J. Schueler, MD; John H. Beckett, MD; D. Scott Gettings, MD
Copyright DSHI Systems, Inc. Powered by: FreeMD - Your Virtual Doctor

PubMed Weight Management References
  1. Cara JF, Chaiken RL.Type 2 diabetes and the metabolic syndrome in children and adolescents. Curr Diab Rep. 2006 Jun;6(3):241-50. [16898579]
  2. Daskalopoulou SS, Athyros VG, Kolovou GD, Anagnostopoulou KK, Mikhailidis DP. Definitions of metabolic syndrome: Where are we now? Curr Vasc Pharmacol. 2006 Jul;4(3):185-97. [16842136]
  3. Holmes KW, Kwiterovich PO Jr. Treatment of dyslipidemia in children and adolescents. Curr Cardiol Rep. 2005 Nov;7(6):445-56. [16256015]
  4. Spanier PA, Marshall SJ, Faulkner GE. Tackling the obesity pandemic: a call for sedentary behaviour research. Can J Public Health. 2006 May-Jun;97(3):255-7. [16827420]
  5. Tremblay A, Therrien F. Physical activity and body functionality: implications for obesity prevention and treatment. Can J Physiol Pharmacol. 2006 Feb;84(2):149-56. [16900940]
FreeMD is provided for information purposes only and should not be used as a substitute for evaluation and treatment by a physician. Please review our terms of use.